Protecting patient access to clinician-administered medications.

HB 3067 (Protecting Patient Access to Clinician-Administered Medications) prevents health insurers and pharmacy benefit managers from restricting patient access to medications that require in-clinic administration by a healthcare provider (e.g., infusion therapies). It prohibits insurers from denying payment for these drugs when medically necessary, charging extra fees for using a patient’s chosen provider, or forcing patients to use specific pharmacies. The bill ensures patients can receive these medications from their preferred provider or pharmacy without financial penalties or coverage restrictions based on location. It directly affects patients requiring clinician-administered drugs and healthcare providers who administer them in clinical settings like offices or hospitals. The law clarifies that insurers may still set copays or deny coverage based on medical necessity, but not on where the drug is obtained.